<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC7059311/results/search/funders/results.xml">
  <result pre="vast majority of patients. The last therapeutic regimens approved by" exact="Food and Drug Administration" post="(FDA) and European Medicines Agency (EMA) are pangenotypic, once-daily,"/>
  <result pre="of treatment (EOT), and 12 weeks after EOT (SVR-12), using the" exact="Siemens" post="Real Time PCR assay (Siemens Healthcare Diagnostics, Tarrytown, NY,"/>
  <result pre="of 15 IU/ml. HCV genotype and subtype were determined using the" exact="Siemens" post="Versant HCV LiPA V2 assay (Siemens, Munich, Germany). Definitions"/>
  <result pre="Elbasvir EMA European Medicines Agency EOT End of treatment FDA" exact="Food and Drug Administration" post="GLE Glecaprevir GRZ Grazoprevir HCV Hepatitis C virus HIV"/>
 </snippets>
</snippetsTree>
